GILENYA 0,25 mg, gélule — plaquettes thermoformées PVC PVDC aluminium de 28 gélules

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400930165942
  • CIP7 3016594
  • CIS 68003070
  • Registration number EU/1/11/677

What the source publishes

Holder
NOVARTIS EUROPHARM (IRLANDE)
Active ingredients
FINGOLIMOD, CHLORHYDRATE DE FINGOLIMOD
Form
gélule
Package
plaquettes thermoformées PVC PVDC aluminium de 28 gélules
Routes
orale
Administrative status
authorised
Supply regime
prescription réservée aux spécialistes et services NEUROLOGIE ; médicament nécessitant une surveillance particulière pendant le traitement ; prescription initiale hospitalière annuelle ; liste I ; la première administration doit être effectuée en milieu hospitalier ; prescription réservée aux spécialistes et services NEUROPEDIATRIE
Marketing status
Déclaration de commercialisation
Authorised on
2018-11-22
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400930165942
{
  "cis": "68003070",
  "cip7": "3016594",
  "form": "gélule",
  "name": "GILENYA 0,25 mg, gélule — plaquettes thermoformées PVC PVDC aluminium de 28 gélules",
  "cip13": "3400930165942",
  "holder": "NOVARTIS EUROPHARM (IRLANDE)",
  "routes": [
    "orale"
  ],
  "holders": [
    "NOVARTIS EUROPHARM (IRLANDE)"
  ],
  "currency": "EUR",
  "marketed": true,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": "580.30",
  "authorisedOn": "2018-11-22",
  "compositions": [
    {
      "name": "FINGOLIMOD",
      "nature": "FT",
      "strength": "0,25 mg",
      "linkageNumber": "1",
      "substanceCode": "85211",
      "dosageReference": "une gélule",
      "pharmaceuticalElement": "gélule"
    },
    {
      "name": "CHLORHYDRATE DE FINGOLIMOD",
      "nature": "SA",
      "strength": null,
      "linkageNumber": "1",
      "substanceCode": "97368",
      "dosageReference": null,
      "pharmaceuticalElement": "gélule"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "prescription réservée aux spécialistes et services NEUROLOGIE ; médicament nécessitant une surveillance particulière pendant le traitement ; prescription initiale hospitalière annuelle ; liste I ; la première administration doit être effectuée en milieu hospitalier ; prescription réservée aux spécialistes et services NEUROPEDIATRIE",
  "dispensingFee": "1.02",
  "medicinePrice": "579.28",
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "GILENYA 0,25 mg, gélule",
  "marketingStatus": "Déclaration de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-11-20",
    "CIS_CIP_bdpm": "2026-11-20",
    "CIS_CPD_bdpm": "2026-11-20",
    "CIS_COMPO_bdpm": "2026-11-20"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "oui",
  "packageDescription": "plaquettes thermoformées PVC PVDC aluminium de 28 gélules",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [
    "65 %"
  ],
  "marketingDeclaredOn": "2019-10-25",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "FINGOLIMOD",
    "CHLORHYDRATE DE FINGOLIMOD"
  ],
  "authorisationProcedure": "Procédure centralisée",
  "prescriptionConditions": [
    "prescription réservée aux spécialistes et services NEUROLOGIE",
    "médicament nécessitant une surveillance particulière pendant le traitement",
    "prescription initiale hospitalière annuelle",
    "liste I",
    "la première administration doit être effectuée en milieu hospitalier",
    "prescription réservée aux spécialistes et services NEUROPEDIATRIE"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": "EU/1/11/677",
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400930165942"